IRME · IR-Med, Inc.
Market Cap
$162,201
Shares
77.24M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.00
Open$0.00
Day$0.00–0.00
52W close$0.00–0.05
Avg vol 30d27K
Short int16K · 0.0% float · 1.0d
Short vol34%
DataJan 2021–Jul 2026
Filing10-Q · Aug 14
Up next
filed Aug 14, 2025
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
−$2.35M
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$63,000
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+4.9%
Year over year · more shares
Price change (1Y)
-91.5%
Trailing year
Short interest
—
Latest settlement
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Bearish
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 15.2 · calm
Equity put/call 0.56
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−100%
below
Price vs 50-day avg
−94%
below
RSI (14)
36
neutral
MACD trend
Negative
52-week position
2%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−96%
trailing
6-month return
−100%
trailing
YTD return
−93%
this year
Relative strength
−107%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.02% of float · ▲ +13252.1% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Fundamentals
EPS growth
+57%
Y/Y
Free cash flow
$-1.4M
Quant / Vol
risk profile
Volatility
587%
annualized · 1-yr
Max drawdown
−100%
past year
ATR
319.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−100%
Bearish
Price vs 50-day avg
−94%
Bearish
RSI (14)
36
Neutral
MACD trend
Negative
Bearish
52-week position
2%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.02% of float · ▲ +13252.1% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0
Now $0 · 2%
Range high $0
vs 200-day avg -100%
vs 50-day avg -94%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
IRME
this stock
IR-Med, Inc.
|
$162,201 | -93.0% | — | — | 0.0% |
|
ABT
Abbott Laboratories
|
$192.64B | -11.8% | +5.7% | 31.0 | 1.2% |
|
SYK
Stryker Corp
|
$121.41B | -11.2% | +11.2% | 32.8 | 1.8% |
|
MDT
Medtronic plc
|
$117.82B | -4.0% | +8.4% | 24.7 | 1.1% |
|
BSX
Boston Scientific Corp
|
$70.10B | -49.3% | +12.5% | 19.6 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| IRME | -32.3% | -95.8% | -99.8% | -70.0% | -93.0% |
| SPY | -0.6% | +0.6% | +6.8% | -1.1% | +8.4% |
| vs SPY | -31.7% | -96.4% | -106.5% | -69.0% | -101.4% |